<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-05-04" modified="2020-10-07" version="193">
<accession>O43541</accession>
<accession>A9J6M5</accession>
<accession>O43654</accession>
<accession>Q15799</accession>
<accession>Q7Z7L4</accession>
<accession>Q96E31</accession>
<accession>Q9UKZ3</accession>
<name>SMAD6_HUMAN</name>
<protein>
<recommendedName>
<fullName>Mothers against decapentaplegic homolog 6</fullName>
<shortName>MAD homolog 6</shortName>
<shortName>Mothers against DPP homolog 6</shortName>
</recommendedName>
<alternativeName>
<fullName>SMAD family member 6</fullName>
<shortName>SMAD 6</shortName>
<shortName>Smad6</shortName>
<shortName>hSMAD6</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SMAD6</name>
<name type="synonym">MADH6</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="347" last="349">
<title>Mad-related genes in the human.</title>
<authorList>
<person name="Riggins G.J."/>
<person name="Thiagalingam S."/>
<person name="Rosenblum E."/>
<person name="Weinstein C.L."/>
<person name="Kern S.E."/>
<person name="Hamilton S.R."/>
<person name="Willson J.K.V."/>
<person name="Markowitz S.D."/>
<person name="Kinzler K.W."/>
<person name="Vogelstein B.V."/>
</authorList>
<dbReference type="PubMed" id="8673135"/>
<dbReference type="DOI" id="10.1038/ng0796-347"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Genes Dev." volume="12" first="186" last="197">
<title>Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor.</title>
<authorList>
<person name="Hata A."/>
<person name="Lagna G."/>
<person name="Massague J."/>
<person name="Hemmati-Brivanlou A."/>
</authorList>
<dbReference type="PubMed" id="9436979"/>
<dbReference type="DOI" id="10.1101/gad.12.2.186"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A)</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ACVR1B; BMPR1B; SMAD1 AND TGFBR1</scope>
<scope>MUTAGENESIS OF GLY-471 AND 478-ARG--ARG-496</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Biochem. Biophys. Res. Commun." volume="249" first="505" last="511">
<title>Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members.</title>
<authorList>
<person name="Afrakhte M."/>
<person name="Moren A."/>
<person name="Jossan S."/>
<person name="Itoh S."/>
<person name="Sampath K."/>
<person name="Westermark B."/>
<person name="Heldin C.H."/>
<person name="Heldin N.E."/>
<person name="ten Dijke P."/>
</authorList>
<dbReference type="PubMed" id="9712726"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.9170"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="1998-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Hagiwara K."/>
<person name="Freeman A.H."/>
<person name="McMenamin M.G."/>
<person name="Bennett W.P."/>
<person name="Nagashima M."/>
<person name="Minter A.R."/>
<person name="Yang K."/>
<person name="Takenoshita S."/>
<person name="Harris C.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM A)</scope>
</reference>
<reference key="5">
<citation type="submission" date="2007-11" db="EMBL/GenBank/DDBJ databases">
<title>Identification of a new SMAD6 variant in human.</title>
<authorList>
<person name="Konrad L."/>
<person name="Scheiber J.A."/>
<person name="Brandt H."/>
<person name="Eickelberg O."/>
<person name="Hofmann R."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM D)</scope>
<source>
<tissue>Prostatic carcinoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A)</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="1998-10" db="EMBL/GenBank/DDBJ databases">
<title>Determination of the genomic structure of human Smad3, Smad6 and Smad7 and the cloning of the human Smad3 promoter.</title>
<authorList>
<person name="Hagiwara K."/>
<person name="Freeman A.A.H."/>
<person name="McMenamin M.G."/>
<person name="Bennett W.P."/>
<person name="Yang K."/>
<person name="Takenoshita S."/>
<person name="Harris C.C."/>
</authorList>
</citation>
<scope>PARTIAL NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM B)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="Annu. Rev. Biochem." volume="67" first="753" last="791">
<title>TGF-beta signal transduction.</title>
<authorList>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="9759503"/>
<dbReference type="DOI" id="10.1146/annurev.biochem.67.1.753"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="Cytokine Growth Factor Rev." volume="10" first="187" last="199">
<title>Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells.</title>
<authorList>
<person name="Verschueren K."/>
<person name="Huylebroeck D."/>
</authorList>
<dbReference type="PubMed" id="10647776"/>
<dbReference type="DOI" id="10.1016/s1359-6101(99)00012-x"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Cytokine Growth Factor Rev." volume="11" first="5" last="13">
<title>The Smad pathway.</title>
<authorList>
<person name="Wrana J.L."/>
<person name="Attisano L."/>
</authorList>
<dbReference type="PubMed" id="10708948"/>
<dbReference type="DOI" id="10.1016/s1359-6101(99)00024-6"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="Cytokine Growth Factor Rev." volume="11" first="15" last="22">
<title>TGF-beta signaling by Smad proteins.</title>
<authorList>
<person name="Miyazono K."/>
</authorList>
<dbReference type="PubMed" id="10708949"/>
<dbReference type="DOI" id="10.1016/s1359-6101(99)00025-8"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="8267" last="8270">
<title>Smad6 as a transcriptional corepressor.</title>
<authorList>
<person name="Bai S."/>
<person name="Shi X."/>
<person name="Yang X."/>
<person name="Cao X."/>
</authorList>
<dbReference type="PubMed" id="10722652"/>
<dbReference type="DOI" id="10.1074/jbc.275.12.8267"/>
</citation>
<scope>INTERACTION WITH HOXC8</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2001" name="Dev. Growth Differ." volume="43" first="115" last="132">
<title>Human truncated Smad 6 (Smad 6s) inhibits the BMP pathway in Xenopus laevis.</title>
<authorList>
<person name="Krishnan P."/>
<person name="King M.W."/>
<person name="Neff A.W."/>
<person name="Sandusky G.E."/>
<person name="Bierman K.L."/>
<person name="Grinnell B."/>
<person name="Smith R.C."/>
</authorList>
<dbReference type="PubMed" id="11284962"/>
<dbReference type="DOI" id="10.1046/j.1440-169x.2001.00562.x"/>
</citation>
<scope>FUNCTION (ISOFORM B)</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="4132" last="4142">
<title>Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.</title>
<authorList>
<person name="Itoh F."/>
<person name="Asao H."/>
<person name="Sugamura K."/>
<person name="Heldin C.-H."/>
<person name="ten Dijke P."/>
<person name="Itoh S."/>
</authorList>
<dbReference type="PubMed" id="11483516"/>
<dbReference type="DOI" id="10.1093/emboj/20.15.4132"/>
</citation>
<scope>INTERACTION WITH STAMBP</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="6458" last="6470">
<title>Arkadia amplifies TGF-beta superfamily signaling through degradation of Smad7.</title>
<authorList>
<person name="Koinuma D."/>
<person name="Shinozaki M."/>
<person name="Komuro A."/>
<person name="Goto K."/>
<person name="Saitoh M."/>
<person name="Hanyu A."/>
<person name="Ebina M."/>
<person name="Nukiwa T."/>
<person name="Miyazawa K."/>
<person name="Imamura T."/>
<person name="Miyazono K."/>
</authorList>
<dbReference type="PubMed" id="14657019"/>
<dbReference type="DOI" id="10.1093/emboj/cdg632"/>
</citation>
<scope>INTERACTION WITH RNF111</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="1646" last="1658">
<title>Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia.</title>
<authorList>
<person name="Liu W."/>
<person name="Rui H."/>
<person name="Wang J."/>
<person name="Lin S."/>
<person name="He Y."/>
<person name="Chen M."/>
<person name="Li Q."/>
<person name="Ye Z."/>
<person name="Zhang S."/>
<person name="Chan S.C."/>
<person name="Chen Y.-G."/>
<person name="Han J."/>
<person name="Lin S.-C."/>
</authorList>
<dbReference type="PubMed" id="16601693"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601057"/>
</citation>
<scope>INTERACTION WITH AXIN1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Nat. Immunol." volume="7" first="1057" last="1065">
<title>Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adapter Pellino-1.</title>
<authorList>
<person name="Choi K.C."/>
<person name="Lee Y.S."/>
<person name="Lim S."/>
<person name="Choi H.K."/>
<person name="Lee C.H."/>
<person name="Lee E.K."/>
<person name="Hong S."/>
<person name="Kim I.H."/>
<person name="Kim S.J."/>
<person name="Park S.H."/>
</authorList>
<dbReference type="PubMed" id="16951688"/>
<dbReference type="DOI" id="10.1038/ni1383"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PELI1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="4086" last="4098">
<title>Smad6 is a protein kinase X phosphorylation substrate and is required for HL-60 cell differentiation.</title>
<authorList>
<person name="Glesne D."/>
<person name="Huberman E."/>
</authorList>
<dbReference type="PubMed" id="16491121"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209436"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PRKX</scope>
<scope>MUTAGENESIS OF SER-435</scope>
<scope>PHOSPHORYLATION AT SER-435</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2012" name="Hum. Mutat." volume="33" first="720" last="727">
<title>Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation.</title>
<authorList>
<person name="Tan H.L."/>
<person name="Glen E."/>
<person name="Topf A."/>
<person name="Hall D."/>
<person name="O'Sullivan J.J."/>
<person name="Sneddon L."/>
<person name="Wren C."/>
<person name="Avery P."/>
<person name="Lewis R.J."/>
<person name="ten Dijke P."/>
<person name="Arthur H.M."/>
<person name="Goodship J.A."/>
<person name="Keavney B.D."/>
</authorList>
<dbReference type="PubMed" id="22275001"/>
<dbReference type="DOI" id="10.1002/humu.22030"/>
</citation>
<scope>INVOLVEMENT IN CONGENITAL CARDIOVASCULAR MALFORMATIONS</scope>
<scope>VARIANT THR-325</scope>
<scope>VARIANTS AOVD2 LEU-415 AND PHE-484</scope>
<scope>CHARACTERIZATION OF VARIANTS AOVD2 LEU-415 AND PHE-484</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="EMBO J." volume="32" first="996" last="1007">
<title>Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6.</title>
<authorList>
<person name="Zhang X."/>
<person name="Zhang J."/>
<person name="Bauer A."/>
<person name="Zhang L."/>
<person name="Selinger D.W."/>
<person name="Lu C.X."/>
<person name="Ten Dijke P."/>
</authorList>
<dbReference type="PubMed" id="23455153"/>
<dbReference type="DOI" id="10.1038/emboj.2013.38"/>
</citation>
<scope>UBIQUITINATION AT LYS-173</scope>
<scope>MUTAGENESIS OF LYS-173</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2016" name="Elife" volume="5">
<title>Two locus inheritance of non-syndromic midline craniosynostosis via rare SMAD6 and common BMP2 alleles.</title>
<authorList>
<person name="Timberlake A.T."/>
<person name="Choi J."/>
<person name="Zaidi S."/>
<person name="Lu Q."/>
<person name="Nelson-Williams C."/>
<person name="Brooks E.D."/>
<person name="Bilguvar K."/>
<person name="Tikhonova I."/>
<person name="Mane S."/>
<person name="Yang J.F."/>
<person name="Sawh-Martinez R."/>
<person name="Persing S."/>
<person name="Zellner E.G."/>
<person name="Loring E."/>
<person name="Chuang C."/>
<person name="Galm A."/>
<person name="Hashim P.W."/>
<person name="Steinbacher D.M."/>
<person name="DiLuna M.L."/>
<person name="Duncan C.C."/>
<person name="Pelphrey K.A."/>
<person name="Zhao H."/>
<person name="Persing J.A."/>
<person name="Lifton R.P."/>
</authorList>
<dbReference type="PubMed" id="27606499"/>
<dbReference type="DOI" id="10.7554/elife.20125"/>
</citation>
<scope>INVOLVEMENT IN CRS7</scope>
<scope>VARIANTS CRS7 223-GLN--ARG-496 DEL; LYS-287; ALA-306; LEU-323; 374-GLU--ARG-496 DEL; CYS-390; 407-GLU--ARG-496 DEL; CYS-465 AND THR-490</scope>
</reference>
<comment type="function">
<text evidence="8 10 14">Acts as a mediator of TGF-beta and BMP antiflammatory activity. Suppresses IL1R-TLR signaling through its direct interaction with PEL1, preventing NF-kappa-B activation, nuclear transport and NF-kappa-B-mediated expression of proinflammatory genes. May block the BMP-SMAD1 signaling pathway by competing with SMAD4 for receptor-activated SMAD1-binding. Binds to regulatory elements in target promoter regions.</text>
</comment>
<comment type="subunit">
<text evidence="1 5 6 7 8 9 10 14">Interacts with NEDD4L (By similarity). Interacts with WWP1 (By similarity). Interacts with STAMBP and PRKX. Interacts with RNF111 and AXIN1. Interacts with TGF-beta type I receptor superfamily members, including ACVR1B, BMPR1B and TGFBR1. In response to BMP2, but not to TGFB treatment, interacts with SMAD1, but not with SMAD2, nor with SMAD4; this interaction may inhibit SMAD1 binding to SMAD4. Interacts with HOXC8 and HOXC9. Interacts with PELI1; this interaction interferes with PELI1 complex formation with TRAF6, IRAK1, IRAK4 and MYD88 in response to IL1B and hence negatively regulates IL1R-TLR signaling.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-976374">
<id>O43541</id>
</interactant>
<interactant intactId="EBI-4302903">
<id>P51817</id>
<label>PRKX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-976374">
<id>O43541</id>
</interactant>
<interactant intactId="EBI-976402">
<id>Q13950</id>
<label>RUNX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-976374">
<id>O43541</id>
</interactant>
<interactant intactId="EBI-1567153">
<id>Q15797</id>
<label>SMAD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-976374">
<id>O43541</id>
</interactant>
<interactant intactId="EBI-976374">
<id>O43541</id>
<label>SMAD6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-4324970">
<id>O43541-2</id>
</interactant>
<interactant intactId="EBI-396676">
<id>O95630</id>
<label>STAMBP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O43541-1</id>
<name>A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O43541-2</id>
<name>B</name>
<name>Smad 6S</name>
<sequence type="described" ref="VSP_006179 VSP_006180"/>
</isoform>
<isoform>
<id>O43541-4</id>
<name>D</name>
<sequence type="described" ref="VSP_035489 VSP_035490"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Ubiquitous in various organs, with higher levels in lung. Isoform B is up-regulated in diseased heart tissue.</text>
</comment>
<comment type="PTM">
<text evidence="8">Phosphorylated by BMP type 1 receptor kinase and by PRKX.</text>
</comment>
<comment type="PTM">
<text evidence="2 12">Monoubiquitinated at Lys-173 by the E2/E3 hybrid ubiquitin-protein ligase UBE2O, leading to reduced binding affinity for the activated BMP type I receptor ACVR1/ALK2, thereby enhancing BMP7 and regulating adipocyte differentiation (PubMed:23455153). Ubiquitinated by WWP1 (By similarity). Ubiquitinated by RNF165, promoting proteasomal degradation, leading to enhance the BMP-Smad signaling (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="2">Arginine methylation by PRMT1, which is recruited by BMPR2, initiates BMP-Induced signaling and induces dissociation from the BMPR1B receptor at the cell surface leading to derepress downstream Smad1/Smad5 signaling.</text>
</comment>
<comment type="disease" evidence="11">
<disease id="DI-03529">
<name>Aortic valve disease 2</name>
<acronym>AOVD2</acronym>
<description>A common defect in the aortic valve in which two rather than three leaflets are present. It is often associated with aortic valve calcification, stenosis and insufficiency. In extreme cases, the blood flow may be so restricted that the left ventricle fails to grow, resulting in hypoplastic left heart syndrome.</description>
<dbReference type="MIM" id="614823"/>
</disease>
<text evidence="11">The disease is caused by mutations affecting the gene represented in this entry. SMAD6 variants may contribute to increased risk of congenital cardiovascular malformations (CVM). CVM is a major cause of mortality and morbidity in childhood. In most sporadic cases that cannot be attributed to particular malformation syndromes or teratogenic exposures, there remains a substantial excess familial risk, indicating a significant genetic contribution to disease susceptibility (PubMed:22275001).</text>
</comment>
<comment type="disease" evidence="13">
<disease id="DI-04994">
<name>Craniosynostosis 7</name>
<acronym>CRS7</acronym>
<description>A form of craniosynostosis, a primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability.</description>
<dbReference type="MIM" id="617439"/>
</disease>
<text evidence="13">Disease susceptibility is associated with variations affecting the gene represented in this entry. Rare heterozygous SMAD6 variants are strongly associated with non-syndromic midline craniosynostosis and confer a very high risk for disease development, in the presence of a common risk allele (rs1884302) near the BMP2 locus.</text>
</comment>
<comment type="similarity">
<text evidence="17">Belongs to the dwarfin/SMAD family.</text>
</comment>
<dbReference type="EMBL" id="U59914">
<property type="protein sequence ID" value="AAC50792.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035528">
<property type="protein sequence ID" value="AAB94137.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF043640">
<property type="protein sequence ID" value="AAC00497.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF037469">
<property type="protein sequence ID" value="AAC82331.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF041065">
<property type="protein sequence ID" value="AAF14343.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF041062">
<property type="protein sequence ID" value="AAF14343.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF041063">
<property type="protein sequence ID" value="AAF14343.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF041064">
<property type="protein sequence ID" value="AAF14343.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AM909653">
<property type="protein sequence ID" value="CAP20377.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012986">
<property type="protein sequence ID" value="AAH12986.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF101474">
<property type="protein sequence ID" value="AAF06841.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10221.1">
<molecule id="O43541-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005576.3">
<molecule id="O43541-1"/>
<property type="nucleotide sequence ID" value="NM_005585.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011519863.1">
<molecule id="O43541-2"/>
<property type="nucleotide sequence ID" value="XM_011521561.2"/>
</dbReference>
<dbReference type="SMR" id="O43541"/>
<dbReference type="BioGRID" id="110266">
<property type="interactions" value="49"/>
</dbReference>
<dbReference type="CORUM" id="O43541"/>
<dbReference type="DIP" id="DIP-36708N"/>
<dbReference type="IntAct" id="O43541">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="MINT" id="O43541"/>
<dbReference type="STRING" id="9606.ENSP00000288840"/>
<dbReference type="iPTMnet" id="O43541"/>
<dbReference type="PhosphoSitePlus" id="O43541"/>
<dbReference type="BioMuta" id="SMAD6"/>
<dbReference type="MassIVE" id="O43541"/>
<dbReference type="MaxQB" id="O43541"/>
<dbReference type="PaxDb" id="O43541"/>
<dbReference type="PeptideAtlas" id="O43541"/>
<dbReference type="PRIDE" id="O43541"/>
<dbReference type="ProteomicsDB" id="49038">
<molecule id="O43541-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="49039">
<molecule id="O43541-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="49040">
<molecule id="O43541-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="13795">
<property type="antibodies" value="567 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000288840">
<molecule id="O43541-1"/>
<property type="protein sequence ID" value="ENSP00000288840"/>
<property type="gene ID" value="ENSG00000137834"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000557916">
<molecule id="O43541-4"/>
<property type="protein sequence ID" value="ENSP00000452955"/>
<property type="gene ID" value="ENSG00000137834"/>
</dbReference>
<dbReference type="GeneID" id="4091"/>
<dbReference type="KEGG" id="hsa:4091"/>
<dbReference type="UCSC" id="uc002aqf.4">
<molecule id="O43541-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4091"/>
<dbReference type="DisGeNET" id="4091"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000137834.14"/>
<dbReference type="GeneCards" id="SMAD6"/>
<dbReference type="HGNC" id="HGNC:6772">
<property type="gene designation" value="SMAD6"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000137834">
<property type="expression patterns" value="Tissue enhanced (lung)"/>
</dbReference>
<dbReference type="MalaCards" id="SMAD6"/>
<dbReference type="MIM" id="602931">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="614823">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="617439">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O43541"/>
<dbReference type="OpenTargets" id="ENSG00000137834"/>
<dbReference type="Orphanet" id="402075">
<property type="disease" value="Familial bicuspid aortic valve"/>
</dbReference>
<dbReference type="PharmGKB" id="PA30529"/>
<dbReference type="eggNOG" id="KOG3701">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000158146"/>
<dbReference type="HOGENOM" id="CLU_026736_2_1_1"/>
<dbReference type="InParanoid" id="O43541"/>
<dbReference type="KO" id="K04677"/>
<dbReference type="OMA" id="CKSFGAQ"/>
<dbReference type="OrthoDB" id="395665at2759"/>
<dbReference type="PhylomeDB" id="O43541"/>
<dbReference type="TreeFam" id="TF314923"/>
<dbReference type="PathwayCommons" id="O43541"/>
<dbReference type="Reactome" id="R-HSA-201451">
<property type="pathway name" value="Signaling by BMP"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8941326">
<property type="pathway name" value="RUNX2 regulates bone development"/>
</dbReference>
<dbReference type="SignaLink" id="O43541"/>
<dbReference type="SIGNOR" id="O43541"/>
<dbReference type="BioGRID-ORCS" id="4091">
<property type="hits" value="19 hits in 894 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SMAD6">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Mothers_against_decapentaplegic_homolog_6"/>
<dbReference type="GenomeRNAi" id="4091"/>
<dbReference type="Pharos" id="O43541">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:O43541"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 15"/>
</dbReference>
<dbReference type="RNAct" id="O43541">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000137834">
<property type="expression patterns" value="Expressed in upper lobe of lung and 224 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O43541">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O43541">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070410">
<property type="term" value="F:co-SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0140416">
<property type="term" value="F:DNA-binding transcription factor inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070411">
<property type="term" value="F:I-SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070412">
<property type="term" value="F:R-SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070698">
<property type="term" value="F:type I activin receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034713">
<property type="term" value="F:type I transforming growth factor beta receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035904">
<property type="term" value="P:aorta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003180">
<property type="term" value="P:aortic valve morphogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030509">
<property type="term" value="P:BMP signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031589">
<property type="term" value="P:cell-substrate adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060976">
<property type="term" value="P:coronary vasculature development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045444">
<property type="term" value="P:fat cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003183">
<property type="term" value="P:mitral valve morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030514">
<property type="term" value="P:negative regulation of BMP signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030279">
<property type="term" value="P:negative regulation of ossification"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045668">
<property type="term" value="P:negative regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060394">
<property type="term" value="P:negative regulation of pathway-restricted SMAD protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010991">
<property type="term" value="P:negative regulation of SMAD protein complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030512">
<property type="term" value="P:negative regulation of transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003148">
<property type="term" value="P:outflow tract septum morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902895">
<property type="term" value="P:positive regulation of pri-miRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003184">
<property type="term" value="P:pulmonary valve morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034616">
<property type="term" value="P:response to laminar fluid shear stress"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007179">
<property type="term" value="P:transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0001657">
<property type="term" value="P:ureteric bud development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003281">
<property type="term" value="P:ventricular septum development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007352">
<property type="term" value="P:zygotic specification of dorsal/ventral axis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.200.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.520.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR013790">
<property type="entry name" value="Dwarfin"/>
</dbReference>
<dbReference type="InterPro" id="IPR003619">
<property type="entry name" value="MAD_homology1_Dwarfin-type"/>
</dbReference>
<dbReference type="InterPro" id="IPR013019">
<property type="entry name" value="MAD_homology_MH1"/>
</dbReference>
<dbReference type="InterPro" id="IPR017855">
<property type="entry name" value="SMAD-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001132">
<property type="entry name" value="SMAD_dom_Dwarfin-type"/>
</dbReference>
<dbReference type="InterPro" id="IPR008984">
<property type="entry name" value="SMAD_FHA_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036578">
<property type="entry name" value="SMAD_MH1_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13703">
<property type="entry name" value="PTHR13703"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03165">
<property type="entry name" value="MH1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03166">
<property type="entry name" value="MH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00523">
<property type="entry name" value="DWA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00524">
<property type="entry name" value="DWB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49879">
<property type="entry name" value="SSF49879"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56366">
<property type="entry name" value="SSF56366"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51075">
<property type="entry name" value="MH1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51076">
<property type="entry name" value="MH2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0989">Craniosynostosis</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Mothers against decapentaplegic homolog 6" id="PRO_0000090869">
<location>
<begin position="1"/>
<end position="496"/>
</location>
</feature>
<feature type="domain" description="MH1" evidence="3">
<location>
<begin position="148"/>
<end position="275"/>
</location>
</feature>
<feature type="domain" description="MH2" evidence="4">
<location>
<begin position="331"/>
<end position="496"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="25"/>
<end position="33"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Arg">
<location>
<begin position="82"/>
<end position="85"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Leu">
<location>
<begin position="165"/>
<end position="168"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="251"/>
<end position="254"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="275"/>
<end position="278"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="1">
<location>
<position position="205"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="1">
<location>
<position position="247"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="1">
<location>
<position position="260"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="1">
<location>
<position position="265"/>
</location>
</feature>
<feature type="modified residue" description="Dimethylated arginine; alternate" evidence="2">
<location>
<position position="75"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="2">
<location>
<position position="75"/>
</location>
</feature>
<feature type="modified residue" description="Dimethylated arginine; alternate" evidence="2">
<location>
<position position="82"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="2">
<location>
<position position="82"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PRKX; in vitro" evidence="4 8">
<location>
<position position="435"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="12">
<location>
<position position="173"/>
</location>
</feature>
<feature type="splice variant" description="In isoform B." id="VSP_006179" evidence="15">
<location>
<begin position="1"/>
<end position="261"/>
</location>
</feature>
<feature type="splice variant" description="In isoform B." id="VSP_006180" evidence="15">
<original>NPYHFSRLCGPE</original>
<variation>MSRMGKPIETQK</variation>
<location>
<begin position="262"/>
<end position="273"/>
</location>
</feature>
<feature type="splice variant" description="In isoform D." id="VSP_035489" evidence="16">
<original>DASMSPDATKPSHWCSVAYWE</original>
<variation>AADAGIGSRGNRGLESSVPCS</variation>
<location>
<begin position="318"/>
<end position="338"/>
</location>
</feature>
<feature type="splice variant" description="In isoform D." id="VSP_035490" evidence="16">
<location>
<begin position="339"/>
<end position="496"/>
</location>
</feature>
<feature type="sequence variant" description="In CRS7; associated with disease susceptibility." id="VAR_078924" evidence="13">
<location>
<begin position="223"/>
<end position="496"/>
</location>
</feature>
<feature type="sequence variant" description="In CRS7; associated with disease susceptibility; dbSNP:rs570279865." id="VAR_078925" evidence="13">
<original>E</original>
<variation>K</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In CRS7; associated with disease susceptibility." id="VAR_077592" evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="sequence variant" description="In CRS7; associated with disease susceptibility; dbSNP:rs1374099442." id="VAR_077593" evidence="13">
<original>P</original>
<variation>L</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with congenital mitral valve prolapse; dbSNP:rs199822239." id="VAR_068074" evidence="11">
<original>A</original>
<variation>T</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="sequence variant" description="In CRS7; associated with disease susceptibility." id="VAR_078926" evidence="13">
<location>
<begin position="374"/>
<end position="496"/>
</location>
</feature>
<feature type="sequence variant" description="In CRS7; associated with disease susceptibility; de novo mutation." id="VAR_077594" evidence="13">
<original>G</original>
<variation>C</variation>
<location>
<position position="390"/>
</location>
</feature>
<feature type="sequence variant" description="In CRS7; associated with disease susceptibility." id="VAR_078927" evidence="13">
<location>
<begin position="407"/>
<end position="496"/>
</location>
</feature>
<feature type="sequence variant" description="In AOVD2; results in significantly lower activity than wild-type in inhibiting BMP signaling in a transcriptional reporter assay; dbSNP:rs387907284." id="VAR_068075" evidence="11">
<original>P</original>
<variation>L</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="sequence variant" description="In CRS7; associated with disease susceptibility; dbSNP:rs761888345." id="VAR_077595" evidence="13">
<original>R</original>
<variation>C</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="sequence variant" description="In AOVD2; results in significantly lower activity than wild-type in inhibiting BMP signaling in a transcriptional reporter assay; dbSNP:rs387907283." id="VAR_068076" evidence="11">
<original>C</original>
<variation>F</variation>
<location>
<position position="484"/>
</location>
</feature>
<feature type="sequence variant" description="In CRS7; associated with disease susceptibility; dbSNP:rs1338294058." id="VAR_078928" evidence="13">
<original>I</original>
<variation>T</variation>
<location>
<position position="490"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes monoubiquitination by UBE2O." evidence="12">
<original>K</original>
<variation>R</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of in vitro phosphorylation by PRKX." evidence="8">
<original>S</original>
<variation>A</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of SMAD1-binding and of inhibition of BMP-SMAD1 signaling. No effect on interaction with BMPR1B and TGFBR1." evidence="14">
<original>G</original>
<variation>S</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with BMPR1B, TGFBR1 and SMAD1." evidence="14">
<location>
<begin position="478"/>
<end position="496"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAB94137." ref="2" evidence="17">
<original>D</original>
<variation>N</variation>
<location>
<position position="21"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O35182"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00438"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00439"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10722652"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11483516"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14657019"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16491121"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16601693"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16951688"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22275001"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23455153"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27606499"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9436979"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8673135"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000303">
<source ref="5"/>
</evidence>
<evidence key="17" type="ECO:0000305"/>
<sequence length="496" mass="53497" checksum="A4B928AE2D34EBC2" modified="2006-10-03" version="2">MFRSKRSGLVRRLWRSRVVPDREEGGSGGGGGGDEDGSLGSRAEPAPRAREGGGCGRSEVRPVAPRRPRDAVGQRGAQGAGRRRRAGGPPRPMSEPGAGAGSSLLDVAEPGGPGWLPESDCETVTCCLFSERDAAGAPRDASDPLAGAALEPAGGGRSREARSRLLLLEQELKTVTYSLLKRLKERSLDTLLEAVESRGGVPGGCVLVPRADLRLGGQPAPPQLLLGRLFRWPDLQHAVELKPLCGCHSFAAAADGPTVCCNPYHFSRLCGPESPPPPYSRLSPRDEYKPLDLSDSTLSYTETEATNSLITAPGEFSDASMSPDATKPSHWCSVAYWEHRTRVGRLYAVYDQAVSIFYDLPQGSGFCLGQLNLEQRSESVRRTRSKIGFGILLSKEPDGVWAYNRGEHPIFVNSPTLDAPGGRALVVRKVPPGYSIKVFDFERSGLQHAPEPDAADGPYDPNSVRISFAKGWGPCYSRQFITSCPCWLEILLNNPR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

